OWCP OTC
OWC Pharmaceutical Research Corp.
1W: +900.0%
1M: +0.0%
3M: +900.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$2M
-110.7% ▼
Capital Expenditures
$28K
-194.4% ▼
Free Cash Flow
-$3M
-111.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$2M
+400.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$5M | -$2M | -$2M | -$5M | -$10M |
| Depreciation & Amort. | $3K | $9K | $10K | $8K | $7K |
| Stock-Based Comp. | $4K | $371 | $1M | $2M | $0 |
| Change in Working Capital | $7K | $55K | $82K | $60K | $190K |
| Other Non-Cash Items | $4M | $374K | $225K | $1M | $2M |
| Operating Cash Flow | -$602K | -$1M | -$529K | -$1M | -$2M |
| — Investing Activities — | |||||
| Capital Expenditures | -$32K | -$3K | -$2K | -$10K | -$28K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$32K | -$3K | -$2K | -$10K | -$28K |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $321K | -$250K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $28K | $0 | $325K | $276K | $105K |
| Financing Cash Flow | $2M | $124K | $646K | $2M | $5M |
| Net Change in Cash | $1M | -$1M | $115K | $498K | $2M |
| Cash End of Period | $1M | $357K | $472K | $971K | $3M |
| Free Cash Flow | -$635K | -$1M | -$531K | -$1M | -$3M |